These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 33521872)

  • 1. Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.
    Salvadó G; Grothe MJ; Groot C; Moscoso A; Schöll M; Gispert JD; Ossenkoppele R;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2212-2224. PubMed ID: 33521872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
    Insel PS; Hansson O; Mattsson-Carlgren N
    JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE effects on regional tau in preclinical Alzheimer's disease.
    Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ;
    Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease.
    Baek MS; Cho H; Lee HS; Lee JH; Ryu YH; Lyoo CH
    Alzheimers Res Ther; 2020 Oct; 12(1):140. PubMed ID: 33129364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
    Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA
    JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of
    Du J; Li A; Shi D; Chen X; Wang Q; Liu Z; Sun K; Guo T;
    Neurology; 2023 Jul; 101(1):e40-e49. PubMed ID: 37188537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals.
    Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y
    Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele.
    Ghisays V; Goradia DD; Protas H; Bauer RJ; Devadas V; Tariot PN; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Caselli RJ; Su Y; Chen K; Reiman EM
    Alzheimers Dement; 2020 Apr; 16(4):598-609. PubMed ID: 31831374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between
    Lee JS; Lee H; Park S; Choe Y; Park YH; Cheon BK; Hahn A; Ossenkoppele R; Kim HJ; Kim S; Yoo H; Jang H; Cho SH; Kim SJ; Kim JP; Jung YH; Park KC; DeCarli C; Weiner MW; Na DL; Seo SW
    Neurology; 2020 Oct; 95(17):e2354-e2365. PubMed ID: 32928967
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Lim YY; Mormino EC;
    Neurology; 2017 Sep; 89(10):1028-1034. PubMed ID: 28794245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner.
    Rubinski A; Dewenter A; Zheng L; Franzmeier N; Stephenson H; Deming Y; Duering M; Gesierich B; Denecke J; Pham AV; Bendlin B; Ewers M;
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1035-1049. PubMed ID: 38049659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.
    Steward A; Biel D; Dewenter A; Roemer S; Wagner F; Dehsarvi A; Rathore S; Otero Svaldi D; Higgins I; Brendel M; Dichgans M; Shcherbinin S; Ewers M; Franzmeier N
    JAMA Neurol; 2023 Dec; 80(12):1295-1306. PubMed ID: 37930695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
    Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing Amyloid-Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.
    Josephs KA; Weigand SD; Whitwell JL
    Neurology; 2022 May; 98(22):e2282-e2292. PubMed ID: 35314506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly.
    Koivumäki M; Ekblad L; Lantero-Rodriguez J; Ashton NJ; Karikari TK; Helin S; Parkkola R; Lötjönen J; Zetterberg H; Blennow K; Rinne JO; Snellman A
    Alzheimers Res Ther; 2024 May; 16(1):112. PubMed ID: 38762725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults.
    Walters S; Contreras AG; Eissman JM; Mukherjee S; Lee ML; Choi SE; Scollard P; Trittschuh EH; Mez JB; Bush WS; Kunkle BW; Naj AC; Peterson A; Gifford KA; Cuccaro ML; Cruchaga C; Pericak-Vance MA; Farrer LA; Wang LS; Haines JL; Jefferson AL; Kukull WA; Keene CD; Saykin AJ; Thompson PM; Martin ER; Bennett DA; Barnes LL; Schneider JA; Crane PK; Hohman TJ; Dumitrescu L;
    JAMA Neurol; 2023 Sep; 80(9):929-939. PubMed ID: 37459083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
    Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
    JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.